Looking at Chiral Technologies 2016
The advancements in molecular research and continued untiring efforts of the research industry to develop better more precisely applicable Pharmaceuticals as well as agro compounds would have not been possible without the advent of Chiral technologies and their applications.
The usage of chiral molecules is at the very center of this technological revolution when coupled with the application of chiral technologies as: Chiral Pool, Resolution, Biocatalysts, or asymmetric analysis creates the required compounds. The majority of development activity is routed through fine chemical companies which are additionally trying to upgrade their capabilities in order to provide to the entire portfolio of pharmaceutical drugs for application in the consumer arena.
Such ramping up of operations by companies in order to develop and upgrade basic molecules for wide ranging applications is also bringing the focus of chiral technologies into the development of clinical cures.
Aruvian Research’s report – Looking at Chiral Technologies - introduces the concept of Chiral Technologies supplementing it with its variants and explaining the actions undertaken by the industry towards developing such compounds jointly and deriving common benefits of clinical nature. The report also analyzes the global market growth forecasts driven by two very important components as Single Isomer Drugs and Single Enantiomer Pharmaceuticals which are synthesized in bulk nature which are contributing to deriving drug streams worldwide.
The report explains the sales of Single Enantiomer pharma on a YOY basis, which is being controlled by certain regulatory constraints. The report also presents an insight on the synergies developed by the industry majors by building long term partnerships as well as sustaining healthy competition which will lead to the development of the industry as a whole.
The market for Chiral Technologies has been demarcated by end user applications in this report further to which the report provides a future perspective on the industry outlook for Chiral Technologies.
The usage of chiral molecules is at the very center of this technological revolution when coupled with the application of chiral technologies as: Chiral Pool, Resolution, Biocatalysts, or asymmetric analysis creates the required compounds. The majority of development activity is routed through fine chemical companies which are additionally trying to upgrade their capabilities in order to provide to the entire portfolio of pharmaceutical drugs for application in the consumer arena.
Such ramping up of operations by companies in order to develop and upgrade basic molecules for wide ranging applications is also bringing the focus of chiral technologies into the development of clinical cures.
Aruvian Research’s report – Looking at Chiral Technologies - introduces the concept of Chiral Technologies supplementing it with its variants and explaining the actions undertaken by the industry towards developing such compounds jointly and deriving common benefits of clinical nature. The report also analyzes the global market growth forecasts driven by two very important components as Single Isomer Drugs and Single Enantiomer Pharmaceuticals which are synthesized in bulk nature which are contributing to deriving drug streams worldwide.
The report explains the sales of Single Enantiomer pharma on a YOY basis, which is being controlled by certain regulatory constraints. The report also presents an insight on the synergies developed by the industry majors by building long term partnerships as well as sustaining healthy competition which will lead to the development of the industry as a whole.
The market for Chiral Technologies has been demarcated by end user applications in this report further to which the report provides a future perspective on the industry outlook for Chiral Technologies.
A. EXECUTIVE SUMMARY
B. UNDERSTANDING THE CHIRAL CONCEPT
B.1 Chiral Technology Variants
B.2 Synergetic Forward Integration - R&D
B.3 Central Role of Molecules in Multi-application
B.4 Deriving Clinical Benefits from Chiral Chemistry
B.5 Chiral Technologies- Development Push
C. INDUSTRY PROFILE
C.1 Chiral Technologies - Opening Markets Globally
C.2 Chiral Market Growth Forecasts & Analysis
C.3 Single Isomer Drugs – Global Sales
C.4 Single Isomer Drugs – Global Market Presence
C.5 Synthesizing Bulk & Active Drugs - Chiral Chemistry
C.6 Chiral Contributions to Drug Streams
C.7 Single Enantiomer Pharmaceuticals – Global Sales
C.8 Single Enantiomer - Pharma Sales
C.9 Chiral Markets – Growth Supplements & Restraints
C.10 Major Intra Industry Partnerships
C.11 Competition in the Industry
D. DIFFERENT CHIRAL MODELS FOR FLEXIBLE MARKETS
E. INTELLECTUAL PROPERTY ISSUES
F. BRINGING THE MOLECULE TO A COMMERCIAL SCALE – ISSUES & CHALLENGES
G. HOW THE PHARMA INDUSTRY IS DRIVING CHIRAL TECHNOLOGIES
H. MARKET DEMARCATIONS BY CHIRAL APPLICATIONS
H.1 Agrochemicals
H.2 Pharmaceuticals
H.3 Flavors & Fragrances, and Other Industries
I. CHIRAL TECHNOLOGY INDUSTRY – FUTURE PERSPECTIVE
J. MAJOR MARKET PLAYERS
J.1 Altus Biologics Inc
J.2 Ascot Fine Chemicals
J.3 Avecia
J.4 Bachem
J.5 Callery Chemical Company
J.6 Cambrex Corporation
J.7 Catalytica Inc
J.8 Chemi SpA
J.9 ChiRex
J.10 ChromTech International
J.11 Daicel Chemical Industries Ltd
J.12 Daiso Company Ltd
J.13 Degussa-H?ls
J.14 DSM
J.15 Great Lakes Fine Chemicals
J.16 IMI (TAMI)
J.17 Johnson Matthey plc
J.18 Kaneka Corporation
J.19 Lonza Ltd
J.20 Novasep
J.21 Oxford Asymmetry International
J.22 Pfanstiehl Laboratories
J.23 PPG-Sipsy
J.24 Sepracor Inc
J.25 Solvias
J.26 Synetix
J.27 Synthon Chiragenics Corporation
K. APPENDIX
L. GLOSSARY OF TERMS
B. UNDERSTANDING THE CHIRAL CONCEPT
B.1 Chiral Technology Variants
B.2 Synergetic Forward Integration - R&D
B.3 Central Role of Molecules in Multi-application
B.4 Deriving Clinical Benefits from Chiral Chemistry
B.5 Chiral Technologies- Development Push
C. INDUSTRY PROFILE
C.1 Chiral Technologies - Opening Markets Globally
C.2 Chiral Market Growth Forecasts & Analysis
C.3 Single Isomer Drugs – Global Sales
C.4 Single Isomer Drugs – Global Market Presence
C.5 Synthesizing Bulk & Active Drugs - Chiral Chemistry
C.6 Chiral Contributions to Drug Streams
C.7 Single Enantiomer Pharmaceuticals – Global Sales
C.8 Single Enantiomer - Pharma Sales
C.9 Chiral Markets – Growth Supplements & Restraints
C.10 Major Intra Industry Partnerships
C.11 Competition in the Industry
D. DIFFERENT CHIRAL MODELS FOR FLEXIBLE MARKETS
E. INTELLECTUAL PROPERTY ISSUES
F. BRINGING THE MOLECULE TO A COMMERCIAL SCALE – ISSUES & CHALLENGES
G. HOW THE PHARMA INDUSTRY IS DRIVING CHIRAL TECHNOLOGIES
H. MARKET DEMARCATIONS BY CHIRAL APPLICATIONS
H.1 Agrochemicals
H.2 Pharmaceuticals
H.3 Flavors & Fragrances, and Other Industries
I. CHIRAL TECHNOLOGY INDUSTRY – FUTURE PERSPECTIVE
J. MAJOR MARKET PLAYERS
J.1 Altus Biologics Inc
J.2 Ascot Fine Chemicals
J.3 Avecia
J.4 Bachem
J.5 Callery Chemical Company
J.6 Cambrex Corporation
J.7 Catalytica Inc
J.8 Chemi SpA
J.9 ChiRex
J.10 ChromTech International
J.11 Daicel Chemical Industries Ltd
J.12 Daiso Company Ltd
J.13 Degussa-H?ls
J.14 DSM
J.15 Great Lakes Fine Chemicals
J.16 IMI (TAMI)
J.17 Johnson Matthey plc
J.18 Kaneka Corporation
J.19 Lonza Ltd
J.20 Novasep
J.21 Oxford Asymmetry International
J.22 Pfanstiehl Laboratories
J.23 PPG-Sipsy
J.24 Sepracor Inc
J.25 Solvias
J.26 Synetix
J.27 Synthon Chiragenics Corporation
K. APPENDIX
L. GLOSSARY OF TERMS
